Ultrathin Orsiro DES: Novel technology, eye-catching cases and robust evidence

 

 

 


CHAIR:

David E. Kandzari

David E. Kandzari, MD
Piedmont Heart Institute
Atlanta, GA

 

FACULTY:


Ron Waksman, MD
MedStar Heart & Vascular Institute
Washington, D.C.

 Sripal Bangalore, MD
New York University School of Medicine
New York, NY		 Thomas Pilgrim, MD
Bern University Hospital
Bern, Switzerland		 Clemens von Birgelen, MD
Thoraxcentrum Twente
Enschede, Netherlands

 


AGENDA:
 

Meet BIOTRONIK VI
Ron Waksman, MD


Product and data overview
David E. Kandzari, MD


What’s the deal with ultrathin struts? The facts.
Sripal Bangalore, MD


What’s the deal with ultrathin struts? Biocompatibility.
Thomas Pilgrim, MD


What’s the deal with ultrathin struts? Effective endothelialization.
Clemens von Birgelen, MD


Key learnings and take away
 


This program was supported by Biotronik AG:  Ultrathin Orsiro DES: Novel technology, eye-catching cases and robust evidence